Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication?

Endocrine Journal

Volumn 54, Issue 4, 2007, Pages 487-495

  Nishikawa, Tetsuo ^a   Saito, Jun ^a   Omura, Masao ^a  

^a YOKOHAMA ROSAI HOSPITAL   (Japan)

Author keywords

Adrenal adenoma; Adrenal hyperplasia; Aldosterone renin ratio (ARR); Hypertension; Plasma aldosterone concentration; Plasma renin activity

Indexed keywords

ALDOSTERONE; RENIN; SODIUM CHLORIDE;

AFRICA; ASIA; AUSTRALIA; BRAIN INFARCTION; EUROPE; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOKALEMIA; INCIDENCE; JAPAN; KIDNEY FAILURE; PREVALENCE; PRIMARY HYPERALDOSTERONISM; REVIEW; SCREENING;

ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERALDOSTERONISM; HYPERTENSION, RENAL; MASS SCREENING; PREVALENCE; RENIN;

EID: 34548688396     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.KR-105     Document Type: Review

References (65)

1. Padfield PL (2003) Prevalence and role of a raised aldosterone to renin ratio in the diagnosis of primary aldosteronism: a debate on the scientific logic of the use of the ratio in practice. Clin Endocrinol 59: 422-426.
2. Conn JW (1955) Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45: 6-17.
3. Conn JW, Cohen EL, Rovner DR (1964) Suppression of plasma renin activity in primary aldosteronism. J Am Med Assoc 190: 213-221.
4. Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr (2000) Prevalence of primary hyperaldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85: 2854-2859.
5. Conn JW (1968) The evolution of primary aldosteronism: 1954-1967. Harvey Lect 62: 257-291.
6. Nadar S, Lip GYH, Beevers DG (2003) Primary hyperaldosteronism. Ann Clin Biochem 40: 439-452.
7. Connell JM (2002) Is there an epidemic of primary hyperaldosteronism. J Hum Hypertens 16: 151-152.
8. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC (1994) High incidence of primary hyperaldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21: 315-318.
9. Lim PO, Dow E, Brennan G, Jung RT, MacDonald TM (2000) High prevalence of primary hyperaldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 14: 311-315.
10. Sherwin RP, Conn JW (1964) Present status of pathology of adrenal gland in hypertension. Am J Surg 107: 136-143.
11. Terzolo M, Ali A, Osella G, Mazza E (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132: 914-919.
12. Ferriss JB, Beevers DG, Brown JJ, Davies DL, Fraser R, Lever AF, Mason P, Neville AM, Robertson JI (1978) Clinical, biochemical and pathological features of low-renin ('primary') hyperaldosteronism. Am Heart J 95: 375-388.
13. Salomon MI, Tchertkoff V (1968) Incidence and role of adrenocortical tumors in hypertension. Geriatrics 23: 184.
14. Russell RP, Masi AT, Ritcher ED (1972) Adrenal cortical adenomas and hypertension. Medicine 51: 211-225.
15. Anderson GH, Blakerman N, Streeten DHP (1994) The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 12: 609-615.
16. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2004) Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res 27: 193-202.
17. Nishikawa T, Omura M (2000) Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 54 (Suppl 1): 83-85.
18. Fishman LM, Kuchel O, Liddle GW, Michelakis AM, Gordon RD, Chick WT (1968) Incidence of primary aldosteronism uncomplicated essential hypertension. JAMA 205: 497-502.
19. Komiya J, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T (1997) An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens 15: 65-72.
20. Gordon R (1999) Incidence and workup of primary aldosteronism - Greenslopes Hospital Series. Primary aldosteronism and adrenal incidentaloma - into a new millennium. Couran Cove Resort, South Stradbroke Island Queensland, Australia, 13 September, p. 13 (Abstract).
21. Young WF Jr (1999) Incidence and workup of primary aldosteronism - Mayo Clinic. Primary aldosteronism and adrenal incidentaloma - into a new millennium. Couran Cove Resort, South Stradbroke Island Queensland, Australia, 13 September, p. 12 (Abstract).
22. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM (1999) Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353: 40.
23. Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J (2000) Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85: 1863-1867.
24. Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F (2002) High prevalence of primary aldosteronism using postocaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15: 896-902.
25. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky J Jr (2003) Prevalence of primary hyperaldosteronism in moderate to severe hypertension to serve hypertension in the Central Europe region. J Hum Hypertens 17: 349-352.
26. Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocinol Metab 89: 1045-1050.
27. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, Conlin PR (2006) Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalemia. J Hum Hypertens 20: 129-136.
28. Kaplan NM (2004) The current epidemic of primary aldosteronism: causes and consequences. J Hypertens 22: 863-869.
29. Rossi GP, Sacchetto A, Pavan E, Palatini P, Graniero GR, Canali C, Pessina AC (1997) Remodeling of the left ventricular in primary aldosteronism due to Conn's adenoma. Circulation 95: 1471-1478.
30. Schmidt BM, Schmieder RE (2003) Aldosterone-induced cardiac damage: focus on blood pressure independent effect. Am J Hypertens 16: 80-86.
31. Sato A, Saruta T (2004) Aldosterone-induced organ damage: plasma aldosterone level and inappropriate salt status. Hypertens Res 27: 303-310.
32. Takeda Y (2004) Pleiotropic action of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist. Hypertens Res 27: 781-789.
33. Kono T, Ikeda F, Oseko F, Imura H, Tanimura H (1981) Normotensive primary aldosteronism: report of a case. J Clin Endocrinol Metab 52: 1009-1013.
34. Brown MA, Cramp HA, Zammit VC, Whitworth JA (1996) Primary aldosteronism: a missed diagnosis in "essential hypertensives"? Aust NZ J Med 26: 533-538.
35. Lim PO, Brennan G, Shiels P, et al. (1998) Unexpectedly high prevalence of primary aldosteronism in a hypertensive population in Dundee, Edinburgh (Abstract). British Endocrine Society. J Endocrinol 156 (Suppl):S1-43.
36. Kumar A, Lall SB, Ammini A, Peshin SS, Karmarkar MG, Talwar KK, Sath SD (1994) Screening of a population of young hypertensives for primary hyperaldosteronism (correspondence). J Hum Hypertens 8: 731-732.
37. Rayner BL, Opie LH, Davidson JS (2000) The aldosterone/renin ratio as a screening test for primary hyperaldosteronism. S Afr Med J 90: 394-400.
38. Plouin PF, Amar L, Chatellier G on behalf of the COMETE-Conn Study Group (2004) Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension. Nephrol Dial Transplant 19: 774-777.
39. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T (1981) A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141: 1589-1593.
40. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC (2001) Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 37: 699-705.
41. Kaplan NM (1998) Primary hypertension: pathogenesis. Clinical Hypertension, 7th edn. Baltimore: Williams and Wilkins, 60-63.
42. Kaplan NM (2001) Cautions over the current epidemic of primary aldosteronism. Lancet 357: 953-954.
43. Tanabe A, Naruse M, Takagi S, Tsuchiya K, Imaki T, Takano K (2003) Variability in the renin-aldosterone profile under random and standardized sampling conditions in primary aldosteronism. J Clin Endocrinol Metab 88: 2489-2494.
44. Montori VM, Young WF Jr (2002) Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin N Am 31: 619-632.
45. Van Buchem FSP, Doorenbos H, Elings HS (1956) Primary aldosteronism due to adrenocortical hyperplasia. Lancet 271: 335-337.
46. Ross EJ (1965) Conn's syndrome due to adrenal hyperplasia with hypertrophy of zona glomerulosa, relieved by unilateral adrenalectomy. Am J Med 39: 994-1002.
47. Banks WA, Kastin AJ, Biglieri EG, Ruiz AE (1984) Primary adrenal hyperplasia: A new subset of primary hyperaldosteronism. J Clin Endocrinol Metab 58: 783-785.
48. Foye LV Jr, Feichtmeir TV (1955) Adrenal cortical carcinoma producing solely mineralocorticoid effect. Am J Med 19: 966-975.
49. Sutherland DJA, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Canad Med Ass J 95: 1109-1119.
50. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL (1991) Clinical and pathological diversity of primary aldosteronism including a new familiar variety. Clin Exp Pharmacol Physiol 18: 283-286.
51. Omura M, Sasano H, Fujiwara T, Yamaguchi K, Nishikawa T (2002) Unique cases of unilateral hyperaldosteronism due to multiple adrenocortical micronodules, which can only be detected by selected adrenal venous sampling. Metabolism 51: 350-355.
52. Weinberger MH, Grim CE, Hollifield JW, Kem DC, Ganguly A, Kramer NJ, Yune HY, Wellman H, Donohue JP (1979) Primary aldosteronism. Ann Intern Med 90: 386-395.
53. Ganguly A (1998) Primary aldosteronism. New Engl J Med 339: 1828-1834.
54. Stewart PM (1999) Mineralocorticoid hypertension. Lancet 353: 1341-1347.
55. Lim PO, Young WF, MacDonald TM (2001) A review of the medical treatment of primary aldosteronism. J Hypertens 19: 353-361.
56. Blumenfeld JD, Sealey JE, Schlussel Y, Vaughan ED Jr, Sos TA, Atlas SA, Muller FB, Acevedo R, Ulick S, Laragh JH (1994) Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 121: 877-885.
57. Weinberger MH, Grim CE, Hollifield JW (1979) Primary hyperaldosteronism. Diagnosis, localization and treatment. Ann Intern Med 67: 403-413.
58. Omura M, Sasano H, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T (2006) Clinical characteristics of aldosterone-producing microadenoma, macroadenoma, and idiopathic hyperaldosteronism in 93 patients with primary aldosteronism. Hypertens Res 29: 883-889.
59. Nishikawa T, Saito J, Omura M (2006) Prospective study on prevalence of aldosterone-producing adenoma and idiopathic hyperaldosteronism among patients with primary aldosteronism. J Tokyo Wom Med Univ 76: 267-269.
60. Phillips JL, Walther MM, Pezzullo JC, Rayford W, Choyke PL, Berman AA, Linehan WM, Doppman JL, Gill JR Jr (2000) Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J Clin Endocrinol Metab 85: 4526-4533.
61. Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA (2004) Role of adrenal venous sampling in primary aldosteronism. Surgery 136: 1227-1235.
62. Rossi GP, Sacchetto A, Chiesura-Corona M, De Toni R, Gallina M, Feltrin GP, Pessina AC (2001) Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 86: 1083-1090.
63. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM (2003) High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 21: 2149-2157.
64. Young WF Jr (2003) Minireview: Primary aldosteronism - changing concepts in diagnosis and treatment. Endocrinology 144: 2208-2213.
65. Kaplan NM (2006) Primary aldosteronism, in Kaplan's Clinical Hypertension, Ninth Edition, Lippincott Williams & Wilkins, p.410-433.